| 000 | 02954 a2200817 4500 | ||
|---|---|---|---|
| 005 | 20250514075749.0 | ||
| 264 | 0 | _c20031219 | |
| 008 | 200312s 0 0 eng d | ||
| 022 | _a0028-3908 | ||
| 024 | 7 |
_a10.1016/s0028-3908(03)00211-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFacci, L | |
| 245 | 0 | 0 |
_aCorticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors. _h[electronic resource] |
| 260 |
_bNeuropharmacology _cOct 2003 |
||
| 300 |
_a623-36 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_a1-Methyl-3-isobutylxanthine _xpharmacology |
| 650 | 0 | 4 | _aAmphibian Proteins |
| 650 | 0 | 4 |
_aAmyloid beta-Peptides _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aBlotting, Western _xmethods |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCerebellum |
| 650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
| 650 | 0 | 4 |
_aChromatin _xmetabolism |
| 650 | 0 | 4 |
_aChromones _xpharmacology |
| 650 | 0 | 4 |
_aColforsin _xpharmacology |
| 650 | 0 | 4 |
_aCorticotropin-Releasing Hormone _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCyclic AMP _xanalogs & derivatives |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xmethods |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xmetabolism |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 |
_aIn Situ Nick-End Labeling _xmethods |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xmetabolism |
| 650 | 0 | 4 |
_aMorpholines _xpharmacology |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 | _aPeptide Hormones |
| 650 | 0 | 4 |
_aPeptides _xpharmacology |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 | _aProtein Serine-Threonine Kinases |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Corticotropin-Releasing Hormone _xmetabolism |
| 650 | 0 | 4 |
_aThionucleotides _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aUrocortins |
| 650 | 0 | 4 |
_aUrotensins _xpharmacology |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 650 | 0 | 4 | _aCRF Receptor, Type 1 |
| 700 | 1 | _aStevens, D A | |
| 700 | 1 | _aPangallo, M | |
| 700 | 1 | _aFranceschini, D | |
| 700 | 1 | _aSkaper, S D | |
| 700 | 1 | _aStrijbos, P J L M | |
| 773 | 0 |
_tNeuropharmacology _gvol. 45 _gno. 5 _gp. 623-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0028-3908(03)00211-9 _zAvailable from publisher's website |
| 999 |
_c12711448 _d12711448 |
||